Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells.

Siebertz B, Stöcker G, Drzeniek Z, Handt S, Just U, Haubeck HD.

Biochem J. 1999 Dec 15;344 Pt 3:937-43.

2.

Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells.

Drzeniek Z, Stöcker G, Siebertz B, Just U, Schroeder T, Ostertag W, Haubeck HD.

Blood. 1999 May 1;93(9):2884-97.

PMID:
10216083
3.

Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5.

Drzeniek Z, Siebertz B, Stöcker G, Just U, Ostertag W, Greiling H, Haubeck HD.

Biochem J. 1997 Oct 15;327 ( Pt 2):473-80.

5.

CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues.

Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, Helmchen U, Löning T, Wagener C.

J Histochem Cytochem. 1996 Jan;44(1):35-41.

PMID:
8543780
8.

The putative role of members of the CEA-gene family (CEA, NCA an BGP) as ligands for the bacterial colonization of different human epithelial tissues.

Leusch HG, Drzeniek Z, Hefta SA, Markos-Pusztai Z, Wagener C.

Zentralbl Bakteriol. 1991 Apr;275(1):118-22.

PMID:
1718301
10.

Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA).

Leusch HG, Hefta SA, Drzeniek Z, Hummel K, Markos-Pusztai Z, Wagener C.

FEBS Lett. 1990 Feb 26;261(2):405-9.

11.

Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen.

Hinoda Y, Neumaier M, Hefta SA, Drzeniek Z, Wagener C, Shively L, Hefta LJ, Shively JE, Paxton RJ.

Proc Natl Acad Sci U S A. 1988 Sep;85(18):6959-63. Erratum in: Proc Natl Acad Sci U S A 1989 Mar;86(5):1668.

12.

Reactivity of glycosidase-treated, blood-group M and N glycopeptides with lectins.

Drzeniek Z, Krotkiewski H, Syper D, Lisowska E.

Carbohydr Res. 1983 Aug 16;120:315-21. No abstract available.

PMID:
6627251
13.
14.

A human antiserum reacting with modified blood group M determinants..

Drzeniek Z, Kúsnierz G, Lisowska E.

Immunol Commun. 1981;10(2):185-97.

PMID:
6169632
15.

M and N blood group antigens: structure and serological specificity.

Lisowska E, Drzeniek Z, Waśniowska K, Kordowicz M.

Acta Haematol Pol. 1980 Apr-Jun;11(2):103-6. No abstract available.

PMID:
6158823
16.
17.

Heterogeneity of aggregates of the human erythrocyte membrane glycoproteins.

Drzeniek Z, Lisowska E.

Arch Immunol Ther Exp (Warsz). 1979;27(1-2):253-62.

PMID:
444038
18.

Affinity purification of antibodies using oligosaccharide-phenethylamine derivaties coupled to Sepharose.

Zopf DA, Smith DF, Drzeniek Z, Tsai CM, Ginburg V.

Methods Enzymol. 1978;50:171-5. No abstract available.

PMID:
661574
19.

[Structure of human erythrocyte membrane and the biochemical basis for its genetic differentiation].

Drzeniek Z.

Postepy Hig Med Dosw. 1977 Jan-Feb;31(1):33-59. Polish. No abstract available.

PMID:
866275
20.

The amino acids of M and N blood group glycopeptides are different.

Waśniowska K, Drzeniek Z, Lisowska E.

Biochem Biophys Res Commun. 1976 May 23;76(2):385-90. No abstract available.

PMID:
1027437
21.

Reactions of erythrocyte glycoproteins and their degradation products with various anti-I sera.

Lisowska E, Dzierzkowa-Borodej W, Seyfried H, Drzeniek Z.

Vox Sang. 1975;28(2):122-32.

PMID:
1114791

Supplemental Content

Loading ...
Support Center